These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35234441)

  • 21. Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells.
    Wan Y; Dai W; Nevagi RJ; Toth I; Moyle PM
    Acta Biomater; 2017 Sep; 59():257-268. PubMed ID: 28655658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninvasive imaging of c(RGD)
    Chen XQ; Liu M; Wang RF; Yan P; Zhang CL; Ma C; Zhao Q; Yin L; Zhao GY; Guo FQ
    J Labelled Comp Radiopharm; 2017 Jul; 60(9):385-393. PubMed ID: 28423195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particles.
    Vader P; Crielaard BJ; van Dommelen SM; van der Meel R; Storm G; Schiffelers RM
    J Control Release; 2012 Jun; 160(2):211-6. PubMed ID: 21983283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of elastin-like polypeptide for targeted specific gene delivery in vivo.
    Yi A; Sim D; Lee YJ; Sarangthem V; Park RW
    J Nanobiotechnology; 2020 Jan; 18(1):15. PubMed ID: 31952530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
    Xu C; Liu W; Hu Y; Li W; Di W
    Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor targeting RGD conjugated bio-reducible polymer for VEGF siRNA expressing plasmid delivery.
    Kim HA; Nam K; Kim SW
    Biomaterials; 2014 Aug; 35(26):7543-52. PubMed ID: 24894645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for "smart" small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells.
    Li G; Hu Z; Yin H; Zhang Y; Huang X; Wang S; Li W
    Int J Nanomedicine; 2013; 8():1293-306. PubMed ID: 23569377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective modification of HK peptides enhances siRNA silencing of tumor targets in vivo.
    Chou ST; Leng Q; Scaria P; Woodle M; Mixson AJ
    Cancer Gene Ther; 2011 Oct; 18(10):707-16. PubMed ID: 21818135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient siRNA transfer to knockdown a placenta specific lncRNA using RGD-modified nano-liposome: A new preeclampsia-like mouse model.
    Yu Q; Qiu Y; Wang X; Tang J; Liu Y; Mei L; Li M; Yang M; Tang L; Gao H; Zhang Z; Xu W; He Q
    Int J Pharm; 2018 Jul; 546(1-2):115-124. PubMed ID: 29729405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy.
    Dong Y; Yu T; Ding L; Laurini E; Huang Y; Zhang M; Weng Y; Lin S; Chen P; Marson D; Jiang Y; Giorgio S; Pricl S; Liu X; Rocchi P; Peng L
    J Am Chem Soc; 2018 Nov; 140(47):16264-16274. PubMed ID: 30346764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chitosan nanoparticles as a dual drug/siRNA delivery system for treatment of colorectal cancer.
    Sadreddini S; Safaralizadeh R; Baradaran B; Aghebati-Maleki L; Hosseinpour-Feizi MA; Shanehbandi D; Jadidi-Niaragh F; Sadreddini S; Kafil HS; Younesi V; Yousefi M
    Immunol Lett; 2017 Jan; 181():79-86. PubMed ID: 27916629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioreducible polyethylenimine-delivered siRNA targeting human telomerase reverse transcriptase inhibits HepG2 cell growth in vitro and in vivo.
    Xia W; Wang P; Lin C; Li Z; Gao X; Wang G; Zhao X
    J Control Release; 2012 Feb; 157(3):427-36. PubMed ID: 22036880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and Function of Engineered Protein Nanocages as a Drug Delivery System for Targeting Pancreatic Cancer Cells via Neuropilin-1.
    Murata M; Narahara S; Kawano T; Hamano N; Piao JS; Kang JH; Ohuchida K; Murakami T; Hashizume M
    Mol Pharm; 2015 May; 12(5):1422-30. PubMed ID: 25811429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic delivery of siRNA by chimeric capsid protein: tumor targeting and RNAi activity in vivo.
    Choi KM; Kim K; Kwon IC; Kim IS; Ahn HJ
    Mol Pharm; 2013 Jan; 10(1):18-25. PubMed ID: 22663765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heat shock protein-mediated cell penetration and cytosolic delivery of macromolecules by a telomerase-derived peptide vaccine.
    Lee SA; Kim BR; Kim BK; Kim DW; Shon WJ; Lee NR; Inn KS; Kim BJ
    Biomaterials; 2013 Oct; 34(30):7495-505. PubMed ID: 23827187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flower-like gold nanoparticles for enhanced photothermal anticancer therapy by the delivery of pooled siRNA to inhibit heat shock stress response.
    Liu Y; Xu M; Zhao Y; Chen X; Zhu X; Wei C; Zhao S; Liu J; Qin X
    J Mater Chem B; 2019 Jan; 7(4):586-597. PubMed ID: 32254792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conjugates of HA2 with octaarginine-grafted HPMA copolymer offer effective siRNA delivery and gene silencing in cancer cells.
    Golan M; Feinshtein V; David A
    Eur J Pharm Biopharm; 2016 Dec; 109():103-112. PubMed ID: 27702685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functionalized bioengineered spider silk spheres improve nuclease resistance and activity of oligonucleotide therapeutics providing a strategy for cancer treatment.
    Kozlowska AK; Florczak A; Smialek M; Dondajewska E; Mackiewicz A; Kortylewski M; Dams-Kozlowska H
    Acta Biomater; 2017 Sep; 59():221-233. PubMed ID: 28694238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD44 targeted delivery of siRNA by using HA-decorated nanotechnologies for KRAS silencing in cancer treatment.
    Tirella A; Kloc-Muniak K; Good L; Ridden J; Ashford M; Puri S; Tirelli N
    Int J Pharm; 2019 Apr; 561():114-123. PubMed ID: 30822503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.